These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Hemolytic disease of the newborn. Prenatal diagnosis, prognosis and intrauterine transfusion in the severely diseased fetus]. Maroni E; Schreiner WE Med Klin; 1969 Mar; 64(13):569-78. PubMed ID: 4891636 [No Abstract] [Full Text] [Related]
27. Diagnosis and management of the Rh-immunized patient. Robertson JG Clin Obstet Gynecol; 1971 Jun; 14(2):494-504. PubMed ID: 4999701 [No Abstract] [Full Text] [Related]
28. Human fetal surgery. Asensio SH Clin Obstet Gynecol; 1974 Sep; 17(3):153-70. PubMed ID: 4278128 [No Abstract] [Full Text] [Related]
29. Amniocentesis and transamniotic fetal transfusion for Rh disease. Queenan JT Clin Obstet Gynecol; 1966 Jun; 9(2):491-507. PubMed ID: 5330419 [No Abstract] [Full Text] [Related]
30. Prenatal intrusion into the amnion. A review of the diagnostic, therapeutic, and research results. Fort AT Am J Obstet Gynecol; 1971 Jun; 110(3):432-55. PubMed ID: 4932527 [No Abstract] [Full Text] [Related]
31. Invasive versus non-invasive testing in red-cell alloimmunized pregnancies. Oepkes D Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):83-9. PubMed ID: 10986439 [TBL] [Abstract][Full Text] [Related]
32. [Foundations of the diagnosis and therapy of hemolytic anemias]. Mey U Z Gesamte Inn Med; 1978 May; 33(9):265-70. PubMed ID: 354230 [No Abstract] [Full Text] [Related]
33. The prenatal intervention of pregnancy complicated with anti-Kell isoimmunization: a review. Sun JB J Matern Fetal Neonatal Med; 2021 Sep; 34(17):2893-2899. PubMed ID: 31571493 [TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of screening test for irregular antibodies]. Nagao N Nihon Rinsho; 2010 Jun; 68 Suppl 6():728-33. PubMed ID: 20942175 [No Abstract] [Full Text] [Related]
35. How the management of erythroblastosis fetalis has changed. Rodeck CH; Letsky E Br J Obstet Gynaecol; 1989 Jul; 96(7):759-63. PubMed ID: 2669931 [No Abstract] [Full Text] [Related]
36. Advances in the theory and practice of exchange transfusions. Phibbs RH Calif Med; 1966 Dec; 105(6):442-53. PubMed ID: 5342893 [TBL] [Abstract][Full Text] [Related]
37. Prenatal testing to predict the severity of hemolytic disease of the fetus and newborn. Contreras M; Garner SF; de Silva M Curr Opin Hematol; 1996 Nov; 3(6):480-4. PubMed ID: 9372121 [TBL] [Abstract][Full Text] [Related]
38. Immunohematological testing and transfusion management of the prenatal patient. Quraishy N; Sapatnekar S Adv Clin Chem; 2023; 117():163-208. PubMed ID: 37973319 [TBL] [Abstract][Full Text] [Related]
39. Hemolytic Disease of the Fetus and Newborn: Historical and Current State. Jackson ME; Baker JM Clin Lab Med; 2021 Mar; 41(1):133-151. PubMed ID: 33494881 [TBL] [Abstract][Full Text] [Related]
40. Hemolytic disease of the fetus and newborn. Moise KJ Clin Adv Hematol Oncol; 2013 Oct; 11(10):664-6. PubMed ID: 24518377 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]